Phase 1 Malignant Peripheral Nerve Sheath Tumors Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Soft Tissue SarcomaMelanomaCarcinoma+13 more

St. Jude Children's Research Hospital48 enrolled1 locationNCT04897321

Recruiting

Phase 1

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Advanced Solid TumorNon-small Cell Lung CancerSolid Tumor+3 more

Bristol-Myers Squibb336 enrolled25 locationsNCT05245500